mirtazapine has been researched along with Cirrhosis in 2 studies
Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Abdelhady, R | 1 |
Cavalu, S | 1 |
Saber, S | 1 |
Elmowafy, R | 1 |
Morsy, NE | 1 |
Ibrahim, S | 1 |
Abdeldaiem, MSI | 1 |
Samy, M | 1 |
Abd-Eldayem, MA | 1 |
Shata, A | 1 |
Elgharabawy, RM | 1 |
Akalay, A | 1 |
Ost, M | 1 |
Hanson, B | 1 |
2 other studies available for mirtazapine and Cirrhosis
Article | Year |
---|---|
Mirtazapine, an atypical antidepressant, mitigates lung fibrosis by suppressing NLPR3 inflammasome and fibrosis-related mediators in endotracheal bleomycin rat model.
Topics: Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Bleomycin; Fibrosis; Idiop | 2023 |
[Mediastinal fibrosis and mirtazapin].
Topics: Antidepressive Agents, Tricyclic; Female; Fibrosis; Humans; Mediastinum; Mianserin; Middle Aged; Mir | 2011 |